These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7876647)

  • 1. Efficacy of an inactivated hepatitis A vaccine in pre- and postexposure conditions in marmosets.
    D'Hondt E; Purcell RH; Emerson SU; Wong DC; Shapiro M; Govindarajan S
    J Infect Dis; 1995 Mar; 171 Suppl 1():S40-3. PubMed ID: 7876647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with an inactivated hepatitis A vaccine.
    Clemens R; Safary A; Hepburn A; Roche C; Stanbury WJ; André FE
    J Infect Dis; 1995 Mar; 171 Suppl 1():S44-9. PubMed ID: 7876648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity.
    Van Damme P; Matheï C; Thoelen S; Meheus A; Safary A; André FE
    J Med Virol; 1994 Dec; 44(4):435-41. PubMed ID: 7897376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence.
    Van Damme P; Thoelen S; Cramm M; De Groote K; Safary A; Meheus A
    J Med Virol; 1994 Dec; 44(4):446-51. PubMed ID: 7897379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An inactivated hepatitis A viral vaccine of cell culture origin.
    Provost PJ; Hughes JV; Miller WJ; Giesa PA; Banker FS; Emini EA
    J Med Virol; 1986 May; 19(1):23-31. PubMed ID: 3009703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later.
    Briem H; Safary A
    J Med Virol; 1994 Dec; 44(4):443-5. PubMed ID: 7897378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A
    Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evaluation of a live hepatitis A vaccine in marmosets.
    Provost PJ; Banker FS; Wadsworth CW; Krah DL
    J Med Virol; 1991 Aug; 34(4):227-31. PubMed ID: 1658214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children.
    Balcarek KB; Bagley MR; Pass RF; Schiff ER; Krause DS
    J Infect Dis; 1995 Mar; 171 Suppl 1():S70-2. PubMed ID: 7876652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host immune response to hepatitis A virus.
    Stapleton JT
    J Infect Dis; 1995 Mar; 171 Suppl 1():S9-14. PubMed ID: 7876654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis A vaccine.
    Med Lett Drugs Ther; 1995 Jun; 37(950):51-2. PubMed ID: 7760768
    [No Abstract]   [Full Text] [Related]  

  • 12. [A trial of a hepatitis A cultured inactivated vaccine on rhesus macaques].
    Shevtsova ZV; Flehmig B; Lapin BA; Esvandzhiia NCh; Krylova RI; Dzhelieva ZN; Tsyganok NM
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (2):55-9. PubMed ID: 7653138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees.
    Purcell RH; D'Hondt E; Bradbury R; Emerson SU; Govindarajan S; Binn L
    Vaccine; 1992; 10 Suppl 1():S148-51. PubMed ID: 1335648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis A virus-specific humoral and cellular immune responses following immunization with a formalin-inactivated hepatitis A vaccine.
    Cederna JB; Klinzman D; Stapleton JT
    Vaccine; 1999 Dec; 18(9-10):892-8. PubMed ID: 10580203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivated hepatitis A vaccine: long-term antibody persistence.
    Wiedermann G; Kundi M; Ambrosch F; Safary A; D'Hondt E; Delem A
    Vaccine; 1997; 15(6-7):612-5. PubMed ID: 9178459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactogenicity and immunogenicity of inactivated hepatitis A vaccines.
    Just M; Berger R
    Vaccine; 1992; 10 Suppl 1():S110-3. PubMed ID: 1362031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hepatitis A in a traveler who had received preexposure inactivated hepatitis A virus vaccine.
    Kurup A; San LM; Yew WS
    Clin Infect Dis; 1999 Jun; 28(6):1324-5. PubMed ID: 10451178
    [No Abstract]   [Full Text] [Related]  

  • 18. [A trial of a cultured inactivated vaccine against hepatitis A on Saguinus mystax tamarins].
    Poleshchuk VF; Balaian MS; Sobol' AV; Titova IP; Guliaeva TV; Dokin VP; Kusov IuIu
    Vopr Virusol; 1990; 35(4):296-9. PubMed ID: 2256314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of hepatitis A vaccine to a military population by needle and jet injector and with hepatitis B vaccine.
    Hoke CH; Egan JE; Sjogren MH; Sanchez J; DeFraites RF; MacArthy PO; Binn LN; Rice R; Burke A; Hill J
    J Infect Dis; 1995 Mar; 171 Suppl 1():S53-60. PubMed ID: 7876650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis A vaccine: persistence of antibodies 5 years after the first vaccination.
    Totos G; Gizaris V; Papaevangelou G
    Vaccine; 1997 Aug; 15(11):1252-3. PubMed ID: 9286052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.